Breath-Holding Episodes in Riboflavin Transporter Deficiency Type 2: A Case Report of Diagnostic Challenges and Successful Riboflavin Treatment
Year: 2026
Type: article
Abstract: Riboflavin transporter deficiency (RTD), previously known as Brown-Vialetto-Van Laere syndrome, is a rare autosomal recessive neurodegenerative disorder characterised by pontobulbar palsy, sensorineural hearing loss, and respiratory compromise. The condition is caused by pathogenic variants in the riboflavin transporter genes SLC52A2 and SLC52A3, which encode the human riboflavin transporters RFVT2 and RFVT3, respectively. Treatment with high-dose riboflavin has been shown to improve clinical outcomes. Several cases have been reported, with considerable variation in age at onset, disease progression, and clinical outcomes. We describe the case of a 19-month-old girl who presented with significant breath-holding episodes, progressive pontobulbar palsy, sensorineural hearing loss, and global developmental delay. Whole-genome sequencing identified a novel homozygous missense variant in SLC52A2, confirming a diagnosis of RTD type 2. The patient required long-term oxygen therapy and percutaneous gastrostomy to support respiration and feeding, respectively. Consistent with findings in other reported cases of RTD, the patient responded favourably to high-dose riboflavin treatment, demonstrating improvements in motor function, although complete neurological recovery was not achieved. RTD should be considered in patients presenting with pontobulbar palsy, sensorineural hearing loss, and respiratory compromise. Breath-holding episodes and apnoeas may provide early clinical clues to the diagnosis. Early recognition is crucial because treatment with high-dose riboflavin may improve clinical outcomes and the potential for neurological recovery.
Source: Cureus
Authors: Abigail Fox, Irina Luca
Language: English
Subfield: Clinical Biochemistry
Domain: Life Sciences
Open Access status: diamond
OpenAlex ID: W7233579317
